Challenges in advanced skin cancer management

What are some of the current challenges in the management of advanced skin cancers, and what is coming next? In this short video, leading skin cancer expert Professor Michael Henderson talks about the emerging role of immune checkpoint inhibitor therapy for advanced non-melanoma skin cancers.

"We may start to see a significant change in the way we approach advanced basal and squamous cell carcinomas."

"We've reached a crossroads in the management of advanced basal cell and squamous cell carcinoma," says Prof Henderson in the video below.

"We have got reasonable agents in hedgehog inhibitors for basal cell cancer, but we know about a third of the patients who are responding stop treatment because of the side effects.

"So we need new agents and we need to do better. And one possibility is going to be the role of immune checkpoint inhibitor therapy. Treating people early, at a stage when their tumour burden is low, immune checkpoint inhibitors work better.

"We may start to see a significant change in the way we approach advanced basal cell cancer in squamous cell cancer."

Watch all this and much more in the full video here:

Interested in skin cancer medicine? Learn more with HealthCert's university-assured and CPD-accredited Professional Diploma program in Skin Cancer Medicine, delivered online or with optional workshops.

Engaging with this blog can help meet your annual  Education Activities CPD requirement!

How to claim your CPD hours If you consume educational webinars, podcasts, articles, or research on this blog, you can Quick Log CPD hours with the RACGP via the usual self-submission process. You will be asked to reflect on what you have learned, and you will require supporting evidence such as a screenshot. Download the RACGP’s guide to self-recording your CPD here